메뉴 건너뛰기




Volumn 162, Issue 1, 2011, Pages 160-165

The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PLACEBO; PROTON PUMP INHIBITOR; TICAGRELOR; VASODILATOR STIMULATED PHOSPHOPROTEIN;

EID: 79960189314     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.11.025     Document Type: Article
Times cited : (75)

References (22)
  • 1
    • 67649610037 scopus 로고    scopus 로고
    • Response variability and the role of platelet function testing
    • P.A. Gurbel, E. Mahla, and M.J. Antonino Response variability and the role of platelet function testing J Invasive Cardiol 21 2009 172 178
    • (2009) J Invasive Cardiol , vol.21 , pp. 172-178
    • Gurbel, P.A.1    Mahla, E.2    Antonino, M.J.3
  • 2
    • 69249219296 scopus 로고    scopus 로고
    • Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
    • A.R. Shuldiner, J.R. O'Connell, and K.P. Bliden Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 2009 849 857
    • (2009) JAMA , vol.302 , pp. 849-857
    • Shuldiner, A.R.1    O'Connell, J.R.2    Bliden, K.P.3
  • 3
    • 73149119363 scopus 로고    scopus 로고
    • Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite
    • M. Kazui, Y. Nishiya, and T. Ishizuka Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite Drug Metab Dispos 38 2010 92 99
    • (2010) Drug Metab Dispos , vol.38 , pp. 92-99
    • Kazui, M.1    Nishiya, Y.2    Ishizuka, T.3
  • 4
    • 58749094444 scopus 로고    scopus 로고
    • Cytochrome p-450 polymorphisms and response to clopidogrel
    • J.L. Mega, S.L. Close, and S.D. Wiviott Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
    • (2009) N Engl J Med , vol.360 , pp. 354-362
    • Mega, J.L.1    Close, S.L.2    Wiviott, S.D.3
  • 5
    • 77953911457 scopus 로고    scopus 로고
    • Consensus and future directions on the definition of high on-treatment platelet reactivity to ADP
    • L. Bonello, U.S. Tantry, and R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to ADP J Am Coll Cardiol 56 2010 919 933
    • (2010) J Am Coll Cardiol , vol.56 , pp. 919-933
    • Bonello, L.1    Tantry, U.S.2    Marcucci, R.3
  • 6
    • 18044398749 scopus 로고    scopus 로고
    • 12 receptor antagonist activity
    • DOI 10.1055/s-2005-869524
    • Y. Niitsu, J.A. Jakubowski, and A. Sugidachi Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity Semin Thromb Hemost 31 2005 184 194 (Pubitemid 40605193)
    • (2005) Seminars in Thrombosis and Hemostasis , vol.31 , Issue.2 , pp. 184-194
    • Niitsu, Y.1    Jakubowski, J.A.2    Sugidachi, A.3    Asai, F.4
  • 7
    • 37849002889 scopus 로고    scopus 로고
    • Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
    • L. Wallentin, C. Varenhorst, and S. James Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease Eur Heart J 29 2008 21 30
    • (2008) Eur Heart J , vol.29 , pp. 21-30
    • Wallentin, L.1    Varenhorst, C.2    James, S.3
  • 8
    • 70149101223 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    • L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
    • (2009) N Engl J Med , vol.361 , pp. 1045-1057
    • Wallentin, L.1    Becker, R.C.2    Budaj, A.3
  • 9
    • 73949112820 scopus 로고    scopus 로고
    • Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/OFFSET study
    • P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
    • (2009) Circulation , vol.120 , pp. 2577-2585
    • Gurbel, P.A.1    Bliden, K.P.2    Butler, K.3
  • 10
    • 77950508416 scopus 로고    scopus 로고
    • Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: The RESPOND study
    • P.A. Gurbel, K.P. Bliden, and K. Butler Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study Circulation 121 2010 1188 1199
    • (2010) Circulation , vol.121 , pp. 1188-1199
    • Gurbel, P.A.1    Bliden, K.P.2    Butler, K.3
  • 11
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • DOI 10.1161/01.CIR.0000072771.11429.83
    • P.A. Gurbel, K.P. Bliden, and B.L. Hiatt Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
    • (2003) Circulation , vol.107 , Issue.23 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3    O'Connor, C.M.4
  • 12
    • 56549090507 scopus 로고    scopus 로고
    • Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: A potential antiplatelet therapeutic target
    • P.A. Gurbel, M.J. Antonino, and K.P. Bliden Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target Platelets 19 2008 595 604
    • (2008) Platelets , vol.19 , pp. 595-604
    • Gurbel, P.A.1    Antonino, M.J.2    Bliden, K.P.3
  • 14
    • 41249093357 scopus 로고    scopus 로고
    • Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance. A Multicenter Randomized Prospective Study
    • DOI 10.1016/j.jacc.2007.12.044, PII S0735109708005664
    • L. Bonello, L. Camoin-Jau, and S. Arques Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2008 1404 1411 (Pubitemid 351447314)
    • (2008) Journal of the American College of Cardiology , vol.51 , Issue.14 , pp. 1404-1411
    • Bonello, L.1    Camoin-Jau, L.2    Arques, S.3    Boyer, C.4    Panagides, D.5    Wittenberg, O.6    Simeoni, M.-C.7    Barragan, P.8    Dignat-George, F.9    Paganelli, F.10
  • 16
    • 77953914877 scopus 로고    scopus 로고
    • Genotyping one piece of the puzzle to personalize antiplatelet therapy
    • P.A. Gurbel, U.S. Tantry, and A.R. Shuldiner Genotyping one piece of the puzzle to personalize antiplatelet therapy J Am Coll Cardiol 56 2010 112 116
    • (2010) J Am Coll Cardiol , vol.56 , pp. 112-116
    • Gurbel, P.A.1    Tantry, U.S.2    Shuldiner, A.R.3
  • 17
    • 79960173071 scopus 로고    scopus 로고
    • Available at:. Last accessed July 28, 2010
    • Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2010/ 020839s042lbl.pdf. Last accessed July 28, 2010.
  • 18
    • 79952598836 scopus 로고    scopus 로고
    • GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: The GRAVITAS randomized trial
    • M.J. Price, P.B. Berger, and P.S. Teirstein GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
    • (2011) JAMA , vol.305 , pp. 1097-1105
    • Price, M.J.1    Berger, P.B.2    Teirstein, P.S.3
  • 19
    • 79960200465 scopus 로고    scopus 로고
    • Available at:. Last accessed July 28, 2010
    • Available at: http://clinicaltrials.gov/ct2/show/NCT00910299?term= TRIGGER-PCI&rank=1. Last accessed July 28, 2010.
  • 20
    • 69549112962 scopus 로고    scopus 로고
    • New P2Y12 antagonists
    • A.D. Michelson New P2Y12 antagonists Curr Opin Hematol 16 2009 371 377
    • (2009) Curr Opin Hematol , vol.16 , pp. 371-377
    • Michelson, A.D.1
  • 21
    • 48449101872 scopus 로고    scopus 로고
    • The association of cigarette smoking with enhanced Platelet inhibition by clopidogrel
    • K.P. Bliden, J. Dichiara, and L. Lawal The association of cigarette smoking with enhanced Platelet inhibition by clopidogrel J Am Coll Cardiol 52 2008 531 533
    • (2008) J Am Coll Cardiol , vol.52 , pp. 531-533
    • Bliden, K.P.1    Dichiara, J.2    Lawal, L.3
  • 22
    • 58349091115 scopus 로고    scopus 로고
    • Relationship between age and platelet activation in patients with stable and unstable angina
    • J.R. Gilstad, P.A. Gurbel, and R.E. Andersen Relationship between age and platelet activation in patients with stable and unstable angina Arch Gerontol Geriatr 48 2009 155 159
    • (2009) Arch Gerontol Geriatr , vol.48 , pp. 155-159
    • Gilstad, J.R.1    Gurbel, P.A.2    Andersen, R.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.